AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2014. - Wikidata - thesis-toulmin - TriplyDB

AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2014.

AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2014.

http://www.wikidata.org/entity/Q34042768

about

Role of Hyperthermia in Breast Cancer Locoregional Recurrence: A Review Targeted Therapies in HER2-Positive Breast Cancer - a Systematic Review A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study Eribulin mesylate in advanced breast cancer: retrospective review of a single institute experience.Impact of guideline-based use of uPA/PAI-1 on patient outcome in intermediate-risk early breast cancer.Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program.Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma - What is the Role of Liquid Biopsy in Breast Cancer?

P2860

Q26753882-D0A1022A-2412-448C-9DC7-08E25CC42D34 Q26777733-03F57C01-7B02-4B75-87B4-BC9910B0E60D Q37575167-346F9576-AEDC-42AD-B084-25176E386053 Q38559355-821D0714-B997-44E8-83E2-759EB826EF26 Q40236856-ACBA73D5-04D9-4205-8F36-8AC0E1BCE7A8 Q41382683-701E31FD-7C84-447B-9365-752AAB180B97 Q47150180-E3734336-C2A2-4797-9CFB-0A5F639D0016

P2860

AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2014.

http://www.wikidata.org/entity/Q34042768

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

AGO Recommendations for the Di ...... ic Breast Cancer: Update 2014.

@ast

AGO Recommendations for the Di ...... ic Breast Cancer: Update 2014.

@en

AGO Recommendations for the Di ...... ic Breast Cancer: Update 2014.

@nl

type

label

AGO Recommendations for the Di ...... ic Breast Cancer: Update 2014.

@ast

AGO Recommendations for the Di ...... ic Breast Cancer: Update 2014.

@en

AGO Recommendations for the Di ...... ic Breast Cancer: Update 2014.

@nl

prefLabel

AGO Recommendations for the Di ...... ic Breast Cancer: Update 2014.

@ast

AGO Recommendations for the Di ...... ic Breast Cancer: Update 2014.

@en

AGO Recommendations for the Di ...... ic Breast Cancer: Update 2014.

@nl

P1433

Q34042768-DB20C6B9-73D7-4656-AA4C-4AD5250216DB

P1476

Q34042768-A6EC0E91-29CF-4A69-A1EA-3D82124AC237

P2093

Q34042768-0A6F6B1D-AFA4-4535-A6B1-DE2FE65421AE

Q34042768-AEC38B2C-BFD8-42E4-9860-7F75B6637DD5

Q34042768-F30B0145-3F4E-4ED5-9CC6-9E0F8B75BFEB

Q34042768-F722C2B7-789D-48CD-BCA3-C9F40E8A7E93

Q34042768-FAAB4961-7ED9-4ACC-9D17-B3F55023448A

P2860

Q34042768-01EB9CA1-3425-45FF-8039-B822704A9A0E

Q34042768-0449F6A9-F768-4318-B4D9-E4A000DAC184

Q34042768-06A4438D-958C-4846-814B-B3EA3EB2627D

Q34042768-131BC82E-534B-4C67-B201-49D8EFDCCFF8

Q34042768-15657B04-7ED1-41D3-91FA-2F046B80EA84

Q34042768-1679FA74-D8E8-40E6-ABE3-913C46C91473

Q34042768-2367EC0E-B542-44E2-B2E4-7B7BF2C56C13

Q34042768-267699DD-13E2-48F9-BC7C-FE6429CD768C

Q34042768-276B5BD2-7C36-488E-9FF5-6244828D8DD1

Q34042768-291678DD-3263-4A15-9F4E-DB601552B0DC

P304

Q34042768-C7221E9D-5AD2-4670-8A19-A9CAEF45B836

P31

Q34042768-064C846B-F319-4E70-ABC0-A1FF0BDC2D3B

P356

Q34042768-426A72E4-70AD-46E6-A08A-E8B694FC907A

P433

Q34042768-10ED7986-8EEF-48FD-8A35-5919AB7B52B9

P478

Q34042768-A42841A1-50A0-4203-BDD0-B0C050E5257A

P577

Q34042768-6F9F233E-BD23-4DA8-B1D0-5771280D8917

P5875

Q34042768-408093BE-5960-4B95-8B1B-A3C6C816713D

P698

Q34042768-332D96D2-DF17-4E7F-9B8A-AEE72FA3C549

P932

Q34042768-E5A1B362-8A8A-472B-AAC2-6E1249FDB6D9

P356

P1433

P1476

AGO Recommendations for the Di ...... ic Breast Cancer: Update 2014.

@en

P2093

AGO Breast Committee

http://www.w3.org/2001/XMLSchema#string

Cornelia Liedtke

http://www.w3.org/2001/XMLSchema#string

Florian Schütz

http://www.w3.org/2001/XMLSchema#string

Marc Thill

http://www.w3.org/2001/XMLSchema#string

Volker Hanf

http://www.w3.org/2001/XMLSchema#string

P2860

Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases

Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer

Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women

Resection of liver metastases from breast cancer: towards a management guideline.

Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial.

Trastuzumab emtansine for HER2-positive advanced breast cancer.

Phase II randomized study of trastuzumab emtansine versus trastuzumab plus docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer

Symptomatic bone marrow involvement in breast cancer--clinical presentation, treatment, and prognosis: a single institution review of 22 cases.

P304

202-209

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000363551

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265214329

http://www.w3.org/2001/XMLSchema#string

P698

25177262

http://www.w3.org/2001/XMLSchema#string

P932

4132248

http://www.w3.org/2001/XMLSchema#string